| Abstrakt: |
A recent report discusses research conducted at Command Hospital in Uttar Pradesh, India, on biologics for the treatment of inflammatory bowel disease (IBD). The researchers state that IBD is a group of chronic inflammatory diseases of the gut, with ulcerative colitis and Crohn's disease being the most common types. The incidence of IBD has been increasing, and biologics and small molecules have become important treatment options. The report provides information on the different drugs used, their clinical pharmacology, indications for use, safety during pregnancy and lactation, and adverse effects. It also highlights recent advances and future perspectives in the use of biologics for IBD. [Extracted from the article] |
